These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9272351)

  • 21. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.
    Meade BD; Deforest A; Edwards KM; Romani TA; Lynn F; O'Brien CH; Swartz CB; Reed GF; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):570-5. PubMed ID: 7659478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of pertussis in U.S. Marine Corps trainees.
    Jansen DL; Gray GC; Putnam SD; Lynn F; Meade BD
    Clin Infect Dis; 1997 Nov; 25(5):1099-107. PubMed ID: 9402365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 26. Pertussis antigens that abrogate bacterial adherence and elicit immunity.
    Brennan MJ; Shahin RD
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S145-9. PubMed ID: 8876533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in serological diagnosis of pertussis by external quality assessment.
    Markey K; Douglas-Bardsley A; Asokanathan C; Fry NK; Barkoff AM; Bacci S; Ködmön C; He Q
    J Med Microbiol; 2019 May; 68(5):741-747. PubMed ID: 30990403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Bordetella pertussis suspensions by ELISA and flow cytometry.
    Jiskoot W; Westdijk J; Reubsaet CH; Beuvery EC
    Adv Exp Med Biol; 1996; 397():153-7. PubMed ID: 8718594
    [No Abstract]   [Full Text] [Related]  

  • 30. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.
    Heininger U; Riffelmann M; Leineweber B; Wirsing von Koenig CH
    Pediatr Infect Dis J; 2009 May; 28(5):443-5. PubMed ID: 19319020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing antibody responses to acellular pertussis vaccines.
    Trollfors B
    Dev Biol Stand; 1997; 89():279-82. PubMed ID: 9272361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin.
    He Q; Viljanen MK; Hinkkanen AE; Arvilommi H; Mertsola J; Viander M
    Vaccine; 2005 May; 23(25):3336-40. PubMed ID: 15837240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preparation of A purified immunogenic pertactin from B. pertussis.
    El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF
    Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative biological activities of acellular pertussis vaccines produced by Kitasato.
    Watanabe M; Izumiya K; Sato T; Yoshino K; Nakagawa N; Ohoishi M; Hoshino M
    Kitasato Arch Exp Med; 1991 Apr; 64(1):31-42. PubMed ID: 1798236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
    Gonik B; Puder KS; Gonik N; Kruger M
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An observation on immunization reaction and serological effect of adsorbed purified pertussis vaccine].
    Tian X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):155-9. PubMed ID: 8221838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of antibodies to pertussis toxin in working reference preparations of anti-pertussis sera from various national control laboratories.
    Relyveld E; Oato NH; Huet M; Gupta RK
    Biologicals; 1992 Mar; 20(1):67-71. PubMed ID: 1610560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.